Dr. Scott Gottlieb says Trump FDA pick Heidi Overton "could be a strong candidate"
Summarized and contextualized by DistantNews.
At a glance
- Dr. Scott Gottlieb, a board member for Pfizer and United Healthcare, commented on President Trump's nominee for FDA leader.
- Gottlieb stated that Dr. Heidi Overton could be a strong candidate for the FDA leadership position.
- He cited her deep policy background as a key qualification for the role.
Dr. Scott Gottlieb, a prominent figure in the healthcare industry and a board member for both Pfizer and United Healthcare, has offered his assessment of President Trump's nominee for the Food and Drug Administration leadership. Speaking on "Face the Nation with Margaret Brennan," Gottlieb indicated that Dr. Heidi Overton possesses the potential to be a strong candidate for the role.
Gottlieb specifically highlighted Dr. Overton's "deep policy background" as a significant asset that could contribute to her effectiveness as FDA commissioner. This suggests that her experience in policy development and implementation is seen as a crucial qualification for navigating the complexities of the agency.
could be a strong candidate
The endorsement, while brief, provides a positive signal regarding Overton's candidacy from a respected former FDA commissioner. The focus on her policy expertise suggests an expectation that the next FDA leader will need a strong understanding of regulatory and legislative matters.
deep policy background
Originally published by CBS News. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.